Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 11 (Search time: 0.018 seconds).
Item hits:
Issue DateTitleAuthor(s)
2015Generating a homology model of the human M1 muscarinic receptor and the design of cognate modulators at this locus for the management of Alzheimer’s diseaseBugeja, Neil J.; Shoemake, Claire
2015The design and optimisation of novel human dihydrofolate reductase inhibitors for the management of proliferative diseasePortelli, Graziella; Shoemake, Claire
2012Optimisation of Tyrosine-based lead molecules capable of Modulation of the Peroxisome Proliferator-Activated Receptor GammaCiantar, J.; Shoemake, Claire; Mangani, C.; Azzopardi, Lilian M.; Serracino-Inglott, Anthony
2017Design of novel compounds with the potential of dual PPARγ/α modulation for the management of metabolic syndromeEllul, Claire; Shoemake, Claire
2016Evaluation and optimization of in silico designed β-Secretase modulators for the treatment of "Alzheimer's Disease"Borg, Luke; Xuereb, Keith; Shoemake, Claire
2017Evaluation and optimization of in silico designed Sphingosine-1-Phosphate (S1P) Receptor Subtype 1 modulators for the management of multiple sclerosisGusman, Daphne H.; Shoemake, Claire
2015A structure-based drug design approach for the identification of novel selective Cyclooxygenase-2 inhibitors using resveratrol analogues as lead moleculesCaruana, Clarissa; Shoemake, Claire
2012Optimisation of abiraterone based non-steroidal lead moleculesGrima, A.; Shoemake, Claire; Azzopardi, Lilian M.; Serracino-Inglott, Anthony
2016Design and optimisation of novel Huperzine A analogues capable of modulating the acetylcholinesterase receptor for the management of Alzheimer’s diseaseBonavia, Sara; Shoemake, Claire
2014Drug design of novel molecules using a bioisosteric and de novo techniques - a comparisonSchembri, Maria; Shoemake, Claire; Sant Fournier, Marianne